ARG1 and neoplasm: Importantly, we found that myeloid cells from MCA203-W30L tumor-bearing mice expressed lower level of both ARG1 and NOS2 enzymes as compared to the control (Figure 3C), that could potentially explain their reduced suppressive activity.